Perineural Therapy Market Trends

  • Report ID: 4161
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Perineural Therapy Market Trends

Growth Drivers

  • Higher Prevalence of Chronic Pain in Global Population Due to Changing Lifestyle- It was observed that around 10% of the global population is affected by chronic pain summing up to approximately 60 million people. Moreover, about one in every 10 people additionally develop chronic pain every year worldwide. Rising digitalization and technological advancement have brought a major change in the physical health of the modern population. People tend to spend more time sitting in either workplaces or educational institutions and do not indulge in physical activities. Such conditions become accountable to trigger chronic pain and other diseases, which require perineural therapy.

  • Spiking Cases of Sports Injuries Resulting in Nerve Damage - Sports injuries are a major cause of neural diseases, which require perineural therapy. Data provided by the National Safety Council stated that bicycling is one of the major causes of sports injuries. The prevalence has increased by 44% in the last decade and 1,260 deaths were noticed in 2020 due to bicycle incidents. 

  • Advancement in Modern Medical Technology - As of 2019, the total revenue of global medical technology was estimated to be around USD 450 billion, which is estimated to cross USD 590 billion by the year 2024. Moreover, the total R&D spending on global medical technology was projected to be about USD 30 billion in 2019.

  • Increment in Global Geriatric Population - According to the data from the World Bank 747.238 million individuals were aged 65 or above in 2021 across the globe. Older adults are more prone to neural disorders and would require immediate treatment.

  • Escalating Approval and Launches of Products to Regenerate and Repair Damaged Nerves - The growing development and launch of medical technologies and drugs, such as neurostimulator devices, are estimated to boost the market growth. The modern perineural injection has been launched in the market with 85% of effectiveness. 

Challenges

  • Lack of Skilled Medical Professionals – The first and foremost challenge that comes along the way has to be the lack of skilled medical professionals. There are not many medical professionals in the world who are associated with this type of treatment this comes as a problem in incorporating this therapy in the treatment of the patients. More knowledge and awareness about this treatment and this field must be circulated so that more medical professionals can come to take part in learning this treatment.
  • Possibilities of Side Effects such as Skin Allergy and Infection
  • Presence of Alternatives owing to the Lack of Awareness

Perineural Therapy Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

15.4%

Base Year Market Size (2023)

USD 346.2 Million

Forecast Year Market Size (2036)

USD 2.22 Billion

Regional Scope

  • North America (U.S. & Canada)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) 
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4161
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of perineural therapy is estimated at USD 394.18 Million.

The perineural therapy market size was over USD 346.2 Million in 2023 and is set to cross USD 2.22 Billion by the end of 2036, growing at more than 15.4% CAGR during the forecast period i.e., between 2024-2036. The higher prevalence of different sorts of neural disorders and the increment in approval of more enhanced products to repair and regenerate nerves are the major factors driving the market growth.

North America is projected to account for majority industry share by 2036, on the back of a higher prevalence of sports injuries.

Boston Scientific Corporation, tVNS Technologies GmbH, Abbott Laboratories, NeuroSigma, Inc., Axogen Corporation, BioWave Limited, Baxter Healthcare Corporation, LivaNova, PLC, Integra LifeSciences Corporation, Soterix Medical, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample